CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $735,889
- in 3 filings
Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Greenleaf Peter Chief Executive Officer | Shares withheld for taxes | −100,890 | $14.21 | $1.4M | 1,840,379 |
| 2026-02-27 | Greenleaf Peter Chief Executive Officer | Grant or award | +196,403 | 1,941,269 | ||
| 2026-02-27 | Greenleaf Peter Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +328,424 | 328,424 | ||
| 2026-02-20 | Greenleaf Peter Chief Executive Officer | Shares withheld for taxes | −100,171 | $14.40 | $1.4M | 1,744,866 |
| 2026-01-02 | Greenleaf Peter Chief Executive Officer | Grant or award | +165,384 | 1,954,329 | ||
| 2026-01-02 | Greenleaf Peter Chief Executive Officer | Shares withheld for taxes | −113,169 | $15.95 | $1.8M | 1,845,037 |
| 2025-03-04 | Greenleaf Peter Chief Executive Officer | Sale | −164,947 | $7.92 | $1.3M | 1,788,945 |
| 2025-03-03 | Greenleaf Peter Chief Executive Officer | Grant or award | +333,705 | 2,149,485 | ||
| 2025-03-03 | Greenleaf Peter Chief Executive Officer | Sale | −195,593 | $8.00 | $1.6M | 1,953,892 |
| 2025-02-28 | Greenleaf Peter Chief Executive Officer | Grant or award | +290,728 | 1,815,780 | ||
| 2025-02-28 | Greenleaf Peter Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +443,973 | 443,973 | ||
| 2024-03-06 | Greenleaf Peter Chief Executive Officer | Sale | −126,981 | $5.60 | $711K | 1,522,114 |
| 2024-02-20 | Greenleaf Peter Chief Executive Officer | Grant or award | +661,538 | 1,649,095 | ||
| 2023-03-02 | Greenleaf Peter Chief Executive Officer | Sale | −33,047 | $8.78 | $290K | 982,671 |
| 2023-03-02 | Greenleaf Peter Chief Executive Officer | Grant or award | +667,407 | 1,015,718 | ||
| 2023-03-02 | Greenleaf Peter Chief Executive Officer | Sale | −32,750 | $8.94 | $293K | 982,968 |
| 2022-03-02 | Greenleaf Peter Chief Executive Officer | Grant or award | +28,300 | 42,035 | ||
| 2022-03-02 | Greenleaf Peter Chief Executive Officer | Sale | −9,068 | $12.01 | $109K | 32,967 |
| 2022-03-02 | Greenleaf Peter Chief Executive Officer | Grant or award · Restricted Stock Unit | +312,240 | 312,240 | ||
| 2022-03-02 | Greenleaf Peter Chief Executive Officer | Grant or award · Stock Option (right to buy) | +534,188 | 534,188 |
Page 1 of 2 · 22 trades